HAVCR1 and autosomal dominant polycystic kidney disease: Regarding KIM-1, our findings are consistence with the results reported by Wang et al. who demonstrated the non-significant effect of metformin on urinary KIM-1 levels after 12 months in autosomal dominant polycystic kidney disease patients [39].